Related Experiment Video
Updated: Jul 15, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left
B M Mayosi1, B Keavney, A Kardos
1Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK.
Insights
Genetic factors significantly influence left ventricular hypertrophy (LVH) measures. Electrocardiography (ECG) measures, particularly Sokolow-Lyon voltage, show higher heritability, suggesting their importance in studying genetic susceptibility to cardiac hypertrophy.
Area of Science:
- Cardiology
- Genetics
- Biometry
Background:
- Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular disease.
- Understanding the genetic contribution to LVH is crucial for identifying individuals at risk.
- Electrocardiography (ECG) and echocardiography are key diagnostic tools for assessing LVH.
Purpose of the Study:
- To determine the heritability of continuous measures of left ventricular hypertrophy (LVH).
- To compare the heritability of LVH assessed by electrocardiography (ECG) and echocardiography.
- To identify which ECG or echocardiographic measures of LVH are most influenced by genetic factors.
Main Methods:
- Studied 955 members from 229 Caucasian families.
- Measured left ventricular hypertrophy (LVH) using standard 12-lead electrocardiograms (ECG) and M-mode echocardiography.
- Estimated heritability using familial correlations and variance components methods, adjusting for covariates and ascertainment.
Main Results:
- Heritability estimates for LVH measures varied between methods.
- Sokolow-Lyon voltage (ECG) showed higher heritability (39-41%) compared to echocardiographic left ventricular mass (23-29%).
- Other ECG measures like Cornell voltage (19-25%) and Cornell product (28-32%) also demonstrated significant heritability.
Conclusions:
- Genetic factors contribute substantially to the variability of quantitative LVH measures.
- Electrocardiographic (ECG) phenotypes, especially Sokolow-Lyon voltage, may be more valuable for investigating the genetic basis of cardiac hypertrophy.
- These findings highlight the potential of ECG in identifying genetic susceptibility to LVH.
Aims:
To assess the heritability (i.e. relative contribution of genetic factors to the variability) of continuous measures of left ventricular hypertrophy determined by electrocardiography and echocardiography.
Methods And Results:
We studied 955 members of 229 Caucasian families, ascertained through a hypertensive proband. Electrocardiographic measurements were performed manually on resting 12-lead electrocardiograms, and echocardiographic measurements were made on M-mode images. Sex-specific residuals for the left ventricular phenotypes were calculated, adjusted for age, systolic blood pressure, weight, height, waist-hip ratio, and presence of diabetes. Heritability was estimated in two ways: firstly, from familial correlations with adjustment for spouse resemblance; and secondly by using variance components methods with ascertainment correction for proband status. The heritability estimates (given as a range derived from the two methods) were higher for Sokolow-Lyon voltage (39-41%) than for echocardiographic left ventricular mass (23-29%). Electrocardiographic left ventricular mass, Cornell voltage, and Cornell product had heritability estimates of 12-18%, 19-25%, and 28-32%, respectively.
Conclusions:
Genetic factors may explain a substantial proportion of variability in quantitative electrocardiographic and echocardiographic measures of left ventricular hypertrophy. The greater heritability of Sokolow-Lyon voltage suggests that electrocardiographic phenotypes may be particularly important for the molecular investigation of the genetic susceptibility to cardiac hypertrophy.
Related Concept Videos
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Heritability
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

